Your session is about to expire
← Back to Search
Early Palliative Care Consultation for Critical Illness
N/A
Waitlist Available
Led By Robert Zalenski, M.D., M.A.
Research Sponsored by Wayne State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Treated in a resuscitation room for unstable vital signs or respiratory compromise
Greater than or equal to 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial is studying whether it's better to have palliative care consultations in the emergency department or later on in the hospital.
Who is the study for?
This trial is for people aged 65 or older who are critically ill with conditions like advanced cancer, severe organ failure, sepsis, dementia, MS, Parkinson's disease or coma after cardiac arrest. They must be in emergency care for serious symptoms and not already enrolled in hospice care or have a do-not-resuscitate order.Check my eligibility
What is being tested?
The study compares the timing of palliative care consultations: one group receives it early in the emergency department while the other gets it later during their ICU or hospital ward stay. Participants are randomly placed into these groups equally.See study design
What are the potential side effects?
Since this trial involves palliative care consultation rather than medication, there aren't typical drug side effects. However, emotional distress or discomfort discussing end-of-life issues could occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I was treated in an emergency room for unstable vital signs or breathing problems.
Select...
I am 65 years old or older.
Select...
I have advanced cancer, severe organ failure, suspected sepsis, advanced dementia/MS/Parkinson's, or am in a coma after cardiac arrest.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The difference in the percentage of patients with a completed advance directive (AD) in Ig vs.Cg
Secondary outcome measures
Amount of hospice referrals in Ig vs. Cg
Average days in hospice in Ig vs. Cg
Hospital and ICU length of stay in Ig vs. Cg
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Interventional group (Ig)Experimental Treatment1 Intervention
The interventional group (Ig) will have an early palliative care consultation ordered during their stay in the emergency department.
Group II: Control group (Cg)Active Control1 Intervention
The control group will be treated as standard of care. Palliative care consultations may or may not be ordered at the attending physician's discretion.
Find a Location
Who is running the clinical trial?
Wayne State UniversityLead Sponsor
307 Previous Clinical Trials
108,344 Total Patients Enrolled
2 Trials studying Sepsis
85 Patients Enrolled for Sepsis
Blue Cross Blue Shield of Michigan FoundationOTHER
27 Previous Clinical Trials
51,080 Total Patients Enrolled
1 Trials studying Sepsis
30 Patients Enrolled for Sepsis
Robert Zalenski, M.D., M.A.Principal InvestigatorWayne State University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was treated in an emergency room for unstable vital signs or breathing problems.I cannot make decisions for myself and have no family to help during my emergency department stay.You are already receiving hospice care before joining the study.You have a bracelet that says "Do Not Resuscitate" (DNR).I am 65 years old or older.I have advanced cancer, severe organ failure, suspected sepsis, advanced dementia/MS/Parkinson's, or am in a coma after cardiac arrest.
Research Study Groups:
This trial has the following groups:- Group 1: Interventional group (Ig)
- Group 2: Control group (Cg)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experimental trial currently recruiting participants?
"The clinical trial website reveals that this particular study is no longer actively enrolling patients. It was initially posted on June 1st, 2016 and its most recent update occurred on August 3rd of the same year. However, there are dozens of other trials in need of recruits right now with 2928 studies currently recruiting participants."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger